REGEND-006

N/A

Report date: 2024/04/24 10:40:18

Base Information

Drug NameREGEND-006
Drug Alias Name自体肺前体细胞REGEND-006REGEND006
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsBronchiectasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesRegend Therapeutics Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesRegend Therapeutics Co LtdJiangxi Xianhe Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsBronchiectasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A